BlueCrest Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-27,900
Closed -$3.17M 117
2024
Q1
$3.17M Sell
27,900
-42,500
-60% -$4.87M 0.16% 93
2023
Q4
$7.75M Buy
70,400
+22,000
+45% +$2.2M 0.3% 69
2023
Q3
$4.69M Buy
48,400
+37,000
+325% +$3.89M 0.21% 77
2023
Q2
$1.24M Buy
+11,400
New +$1.22M 0.04% 135
2022
Q1
Sell
-70,000
Closed -$9.85M 273
2021
Q4
$9.85M Buy
+70,000
New +$8.96M 0.32% 62

Other funds holding ABT

BlueCrest Capital Management's ABT Position: Q1 2024 in Review

BlueCrest Capital Management sold out of Abbott (ABT) in Q1 2024, closing a stake of 11,040 shares — an estimated $1.27M sold.

BlueCrest Capital Management first reported a position in ABT in Q1 2015 and held it in 12 quarters. The position peaked at $4.62M in Q1 2017. 2,904 funds tracked by Wall St. Rank hold ABT as of Q1 2024.

  • BlueCrest Capital Management reported no remaining Abbott position as of Q1 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 11,040 Abbott shares in Q1 2024, an estimated $1.27M.
  • BlueCrest Capital Management first reported a position in Abbott in Q1 2015 and held it in 12 quarters.
  • BlueCrest Capital Management's Abbott position peaked at $4.62M in Q1 2017.
  • 2,904 funds tracked by Wall St. Rank held Abbott as of Q1 2024.

Based on BlueCrest Capital Management's 13F filing for Q1 2024, filed 15 May 2024.